论文信息 - Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49. - 字舞流文

Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49.

T. de Baère | M. Ducreux | C. Lepage | L. Mineur | J. Taieb | O. Pellerin | B. Lapuyade | D. Tougeron | S. Pernot | Denis Smith | C. Lécaille | A. Thirot-Bidault | C. Gallois | C. Montérymard | F. Khemissa Akouz | F. Audemar | Mireille Simon | Samira Louafi | A. Thirot‐Bidault | Faiza Khemissa Akouz